• Mashup Score: 0

    Rheumatologists had high hopes for belimumab as the first lupus biologic, but despite even more positive data coming out of the BLISS-LN trial presented at EULAR, access remains an issue in Australia.

    Tweet Tweets with this article
    • Access to belimumab still a strugglet as the drug hadn’t been listed on the PBS even after decades of research. “ treatments lag behind other diseases like RA,” said Associate Professor Alberta Hoi. https://t.co/3Ywjxhfnab

  • Mashup Score: 0

    The latest figures from the Australian Institute of Health and Welfare, published last month in an updated report, highlight the burden of this disease among Australians of all ages.

    Tweet Tweets with this article
    • “There has been considerable effort in recent decades to accelerate early diagnosis and treatment...and we now recognise that people of all ages can develop RA for the first time,” Professor Proudman said. https://t.co/mr5INb0LrC

  • Mashup Score: 0

    Chronic cough, lung fibrosis, fatigue and dyspnoea could be in store for those who recover from a bad bout.

    Tweet Tweets with this article
    • To date, there has been very little research published on what symptoms patients are experiencing post-recovery from the current pandemic viral infection. So where does that leave us? The reality is we don’t know yet. https://t.co/w6Gvf9i4Hd